Finding the right dose: study tests lower rituximab amounts for severe skin disease
NCT ID NCT07457944
Summary
This study looked back at the medical records of 275 people with pemphigus, a severe autoimmune disease that causes painful skin blisters. Researchers compared how well different doses of the drug rituximab worked to control the disease and prevent it from coming back. The goal was to find the most effective and safest dose for long-term management.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PEMPHIGUS DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Department of Dermatology, Rui Jin Hospital, Shanghai Jiao Tong University School of Medicine
Shanghai, Shanghai Municipality, China
Conditions
Explore the condition pages connected to this study.